NFE2L2 and chronic kidney disease: It should be noted that early Nrf2 activation has been shown to have protective effects in a variety of models of AKI and CKD that are closely related to improvements in mitochondrial homeostasis, and late activation of Nrf2 has been shown to be associated with severe adverse effects in clinical trials conducted in patients with late-stage CKD (Figure 3).